OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases
Raida Khwaja, Andrew Daly, Michael K. Wong, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2016) Vol. 57, Iss. 11, pp. 2720-2722
Closed Access | Times Cited: 38
Raida Khwaja, Andrew Daly, Michael K. Wong, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2016) Vol. 57, Iss. 11, pp. 2720-2722
Closed Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 111
Maria Rosaria Sapienza, Alessandro Pileri, Enrico Derenzini, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 595-595
Open Access | Times Cited: 111
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé, et al.
Blood Advances (2019) Vol. 3, Iss. 24, pp. 4238-4251
Open Access | Times Cited: 104
Treatment of blastic plasmacytoid dendritic cell neoplasm
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Jill M. Sullivan, David A. Rizzieri
Hematology (2016) Vol. 2016, Iss. 1, pp. 16-23
Open Access | Times Cited: 92
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Maria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 729-737
Open Access | Times Cited: 69
Maria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 729-737
Open Access | Times Cited: 69
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review
Marie JeongMin Kim, Ahmed Nasr, Bilaal Kabir, et al.
Journal of Pediatric Hematology/Oncology (2017) Vol. 39, Iss. 7, pp. 528-537
Closed Access | Times Cited: 53
Marie JeongMin Kim, Ahmed Nasr, Bilaal Kabir, et al.
Journal of Pediatric Hematology/Oncology (2017) Vol. 39, Iss. 7, pp. 528-537
Closed Access | Times Cited: 53
Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 47
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 47
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Blastic Plasmacytoid Dendritic Cell Neoplasm
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 35
Daniel Kerr, Ling Zhang, Lubomir Sokol
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 1
Closed Access | Times Cited: 35
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm
Naseema Gangat, Marina Konopleva, Mrinal M. Patnaik, et al.
American Journal of Hematology (2021) Vol. 97, Iss. 2
Open Access | Times Cited: 26
Naseema Gangat, Marina Konopleva, Mrinal M. Patnaik, et al.
American Journal of Hematology (2021) Vol. 97, Iss. 2
Open Access | Times Cited: 26
The advances in therapy of blastic plasmacytoid dendritic cell neoplasm
Daniel Kerr, Lubomir Sokol
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 9, pp. 733-739
Closed Access | Times Cited: 22
Daniel Kerr, Lubomir Sokol
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 9, pp. 733-739
Closed Access | Times Cited: 22
Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents
Shunan Wang, Xingtong Wang, Mingsuo Liu, et al.
Annals of Hematology (2018) Vol. 97, Iss. 4, pp. 563-572
Closed Access | Times Cited: 21
Shunan Wang, Xingtong Wang, Mingsuo Liu, et al.
Annals of Hematology (2018) Vol. 97, Iss. 4, pp. 563-572
Closed Access | Times Cited: 21
Blastic Plasmacytoid Dendritic Cell Neoplasm in Children
Yixian Li, Victoria Sun, Weili Sun, et al.
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 601-612
Closed Access | Times Cited: 20
Yixian Li, Victoria Sun, Weili Sun, et al.
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 601-612
Closed Access | Times Cited: 20
New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19
Xiang Zhang, Jiewen Sun, Min Yang, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 149, pp. 102928-102928
Closed Access | Times Cited: 19
Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review
Yemin Wang, Xiao Li, Lili Yin, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32904-e32904
Open Access | Times Cited: 7
Yemin Wang, Xiao Li, Lili Yin, et al.
Medicine (2023) Vol. 102, Iss. 7, pp. e32904-e32904
Open Access | Times Cited: 7
Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells
Florian Renosi, Mary Callanan, Christine Lefebvre
Cancers (2022) Vol. 14, Iss. 17, pp. 4132-4132
Open Access | Times Cited: 11
Florian Renosi, Mary Callanan, Christine Lefebvre
Cancers (2022) Vol. 14, Iss. 17, pp. 4132-4132
Open Access | Times Cited: 11
Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment
Xiaoning Wang, Jiashuo Guo, Yan Liu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Xiaoning Wang, Jiashuo Guo, Yan Liu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm
Umberto Falcone, Hassan Sibai, Uday Deotare
Critical Reviews in Oncology/Hematology (2016) Vol. 107, pp. 156-162
Closed Access | Times Cited: 17
Umberto Falcone, Hassan Sibai, Uday Deotare
Critical Reviews in Oncology/Hematology (2016) Vol. 107, pp. 156-162
Closed Access | Times Cited: 17
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
Amy M. Trottier, Sonia Cerquozzi, Carolyn Owen
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 85-93
Open Access | Times Cited: 17
Amy M. Trottier, Sonia Cerquozzi, Carolyn Owen
Blood and Lymphatic Cancer Targets and Therapy (2017) Vol. Volume 7, pp. 85-93
Open Access | Times Cited: 17
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm
Minas P. Economides, Marina Konopleva, Naveen Pemmaraju
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 16
Minas P. Economides, Marina Konopleva, Naveen Pemmaraju
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 16
Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm
Maria Rosaria Sapienza, Stefano Pileri
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 511-521
Closed Access | Times Cited: 16
Maria Rosaria Sapienza, Stefano Pileri
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 511-521
Closed Access | Times Cited: 16
Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm
Michael Haddadin, Justin Taylor
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 539-552
Closed Access | Times Cited: 15
Michael Haddadin, Justin Taylor
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 539-552
Closed Access | Times Cited: 15
Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm
Andrew A. Lane
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 589-600
Closed Access | Times Cited: 15
Andrew A. Lane
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 589-600
Closed Access | Times Cited: 15
Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Minas P. Economides, David A. Rizzieri, Naveen Pemmaraju
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 6, pp. 515-522
Closed Access | Times Cited: 13
Minas P. Economides, David A. Rizzieri, Naveen Pemmaraju
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 6, pp. 515-522
Closed Access | Times Cited: 13
A case series of blastic plasmacytoid dendritic cell neoplasia
Valentina Giudice
Translational Medicine UniSa (2020) Vol. 23, Iss. 4
Open Access | Times Cited: 12
Valentina Giudice
Translational Medicine UniSa (2020) Vol. 23, Iss. 4
Open Access | Times Cited: 12
Dendritic Cell Leukemia: a Review
Nikolaos J. Tsagarakis, Georgios Paterakis
Current Oncology Reports (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 11
Nikolaos J. Tsagarakis, Georgios Paterakis
Current Oncology Reports (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 11
